Clinical Trial Update: Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reduced-intensity conditioning before allogeneic transplant in patients with relapsed lymphoma (Hodgkin's or non-Hodgkin's) terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2013-02-08